Complete Filing Data
Bolt Biotherapeutics, Inc. reported Stockholders Equity of $26.51 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Bolt Biotherapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$33.4M | -$63.1M | -$69.2M | -$88.1M | -$98.6M | -$60.7M |
| Research And Development Expense | $28.5M | $57.5M | $61.5M | $73.1M | $75.7M | $40.4M |
| Operating Income Loss | -$36.1M | -$73.0M | -$76.2M | -$90.3M | -$92.8M | -$49.2M |
| Operating Expenses | $43.8M | $80.7M | $84.1M | $96.1M | $94.0M | $49.4M |
| Nonoperating Income Expense | $2.7M | $9.9M | $7.0M | $2.2M | -$5.8M | -$11.5M |
| General And Administrative Expense | $13.8M | $18.5M | $22.5M | $22.9M | $18.4M | $9.1M |
| Comprehensive Income Net Of Tax | -$33.5M | -$63.1M | -$68.2M | -$88.7M | -$98.9M | -$60.7M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$118.0K | $60.0K | $956.0K | -$598.0K | -$321.0K | |
| Revenues | $7.7M | $7.7M | $7.9M | $5.7M | $1.3M | $231.0K |
| Deferred Revenue Current | $449.0K | $3.0M | $2.2M | $2.0M | $2.9M | $1.5M |
| Deferred Revenue Noncurrent | $1.5M | $3.6M | $9.1M | $12.9M | $14.2M | |
| Restructuring Charges | $1.5M | $3.3M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$7.1M | -$8.6M | -$11.0M | -$15.2M | -$21.2M | -$10.8M | -$16.3M | -$18.1M | -$17.0M | -$21.8M | -$22.7M | -$23.7M | -$23.4M | -$23.6M | -$24.5M | -$10.0M | -$11.1M | -$8.6M |
| Research And Development Expense | $6.5M | $7.5M | $9.5M | $13.8M | $15.4M | $16.5M | $15.0M | $15.6M | $14.6M | $19.0M | $18.9M | $18.4M | $19.3M | $19.7M | $14.1M | $9.5M | $9.2M | $6.8M |
| Operating Income Loss | -$7.7M | -$9.2M | -$12.1M | -$16.4M | -$22.6M | -$17.1M | -$18.2M | -$19.8M | -$18.4M | -$22.3M | -$23.1M | -$23.9M | -$23.5M | -$23.8M | -$18.4M | -$12.4M | -$11.1M | -$8.7M |
| Operating Expenses | $9.9M | $11.0M | $13.3M | $17.6M | $23.9M | $22.4M | $20.7M | $21.3M | $20.2M | $24.5M | $24.5M | $24.7M | $24.3M | $23.8M | $18.4M | $12.4M | $11.2M | $8.9M |
| Nonoperating Income Expense | $559.0K | $649.0K | $1.1M | $1.3M | $1.4M | $6.3M | $1.9M | $1.8M | $1.4M | $587.0K | $395.0K | $198.0K | $131.0K | $176.0K | -$6.0M | $2.4M | $51.0K | $112.0K |
| General And Administrative Expense | $3.3M | $3.5M | $3.8M | $3.8M | $4.9M | $5.8M | $5.8M | $5.6M | $5.6M | $5.5M | $5.5M | $6.3M | $4.9M | $4.1M | $4.3M | $2.9M | $2.0M | $2.1M |
| Comprehensive Income Net Of Tax | -$7.1M | -$8.6M | -$11.1M | -$14.9M | -$21.2M | -$10.9M | -$16.2M | -$18.1M | -$16.3M | -$21.7M | -$23.1M | -$24.8M | -$23.4M | -$23.5M | -$24.5M | -$10.0M | -$11.0M | -$8.6M |
| Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax | -$4.0K | -$46.0K | -$57.0K | $249.0K | -$8.0K | -$73.0K | $55.0K | $6.0K | $684.0K | $94.0K | -$407.0K | -$1.1M | -$15.0K | $41.0K | -$64.0K | $1.0K | $11.0K | -$10.0K |
| Revenues | $2.2M | $1.8M | $1.2M | $1.1M | $1.3M | $5.3M | $2.5M | $1.4M | $1.8M | $2.1M | $1.4M | $813.0K | $752.0K | $0.00 | $67.0K | $164.0K | ||
| Deferred Revenue Current | $1.9M | $2.5M | $3.1M | $2.0M | $2.0M | $1.9M | $1.9M | $1.7M | $1.6M | $3.2M | $3.5M | $3.4M | $5.2M | $4.3M | $1.5M | |||
| Deferred Revenue Noncurrent | $2.0M | $2.6M | $3.0M | $3.9M | $4.5M | $5.3M | $10.1M | $12.0M | $12.6M | $11.8M | $12.7M | $13.6M | $12.2M | $8.5M | ||||
| Restructuring Charges | $0.00 | $0.00 | $0.00 | $3.6M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $26.5M | $57.2M | $112.7M | $171.5M | $250.1M | -$104.9M | -$45.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $13.4M | $9.0M | $12.6M | $10.8M | $28.9M | $7.1M | $35.4M |
| Cash And Cash Equivalents At Carrying Value | $11.7M | $7.2M | $10.8M | $9.2M | $27.4M | $5.5M | |
| Short Term Investments | $15.8M | $40.1M | $91.4M | $159.6M | $158.8M | $17.3M | |
| Retained Earnings Accumulated Deficit | -$460.8M | -$427.4M | -$364.3M | -$295.1M | -$207.0M | -$108.4M | |
| Restricted Cash Noncurrent | $1.5M | $981.0K | $1.8M | $1.6M | $1.6M | $1.6M | |
| Restricted Cash And Cash Equivalents At Carrying Value | $1.7M | $1.8M | $1.8M | $1.6M | $1.6M | $1.6M | |
| Property Plant And Equipment Net | $1.2M | $3.1M | $5.0M | $6.5M | $6.2M | $4.1M | |
| Prepaid Expense And Other Assets Current | $2.6M | $2.7M | $3.5M | $3.9M | $2.9M | $2.5M | |
| Other Liabilities Noncurrent | $132.0K | $0.00 | $43.0K | $42.0K | $210.0K | $329.0K | |
| Other Assets Noncurrent | $138.0K | $62.0K | $1.8M | $1.0M | $1.0M | $909.0K | |
| Operating Lease Right Of Use Asset | $19.2M | $21.8M | $19.1M | $22.1M | $24.4M | $12.3M | |
| Operating Lease Liability Noncurrent | $20.1M | $23.0M | $17.4M | $20.2M | $21.9M | $9.4M | |
| Operating Lease Liability Current | $2.8M | $2.3M | $2.8M | $2.4M | $2.5M | $1.5M | |
| Liabilities Current | $8.4M | $15.9M | $20.5M | $23.1M | $21.3M | $11.3M | |
| Liabilities And Stockholders Equity | $56.7M | $99.6M | $159.8M | $227.8M | $307.7M | $46.5M | |
| Liabilities | $30.2M | $42.4M | $47.0M | $56.3M | $57.6M | $46.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $4.5M | -$3.6M | $1.8M | -$18.1M | $21.8M | -$28.3M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $13.4M | $9.0M | $12.6M | $10.8M | $28.9M | $7.1M | |
| Assets Current | $30.3M | $50.8M | $105.7M | $172.7M | $189.2M | $25.4M | |
| Assets | $56.7M | $99.6M | $159.8M | $227.8M | $307.7M | $46.5M | |
| Additional Paid In Capital Common Stock | $487.3M | $484.5M | $477.0M | $467.5M | $457.4M | $3.5M | |
| Accrued Expenses And Other Current Liabilities | $3.7M | $9.1M | $12.5M | $15.1M | $12.4M | $6.7M | |
| Accounts Payable Current | $1.4M | $1.5M | $3.0M | $3.6M | $3.6M | $1.6M | |
| Operating Lease Right Of Use Asset Amortization Expense | $2.5M | $2.3M | $3.0M | $3.2M | $2.5M | $1.9M | |
| Accretion Amortization Of Discounts And Premiums Investments | $670.0K | $2.6M | $4.5M | -$184.0K | -$2.7M | -$34.0K | |
| Long Term Investments | $4.3M | $22.9M | $26.4M | $23.9M | $85.3M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$21.0K | $97.0K | $37.0K | -$919.0K | -$321.0K | ||
| Common Stock Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Deferred Offering Costs In Accounts Payable And Accrued Liabilities | $102.0K | $102.0K | $390.0K | ||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $0.00 | $6.4M | $0.00 | $852.0K | $14.7M | $4.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $32.1M | $38.8M | $46.8M | $72.0M | $85.9M | $104.2M | $128.3M | $142.1M | $157.7M | $188.4M | $208.0M | $228.4M | $274.9M | $295.9M | $303.2M | -$74.6M | -$65.0M | -$54.2M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $19.5M | $11.4M | $10.2M | $11.1M | $8.0M | $6.0M | $10.9M | $15.0M | $16.4M | $12.2M | $24.2M | $45.6M | $25.2M | $59.9M | $97.0M | $19.4M | $45.9M | $12.2M |
| Cash And Cash Equivalents At Carrying Value | $17.8M | $9.6M | $8.4M | $9.4M | $6.2M | $4.3M | $9.2M | $13.5M | $14.8M | $10.6M | $22.6M | $44.0M | $23.6M | $58.3M | $95.5M | $17.8M | $45.3M | $11.6M |
| Short Term Investments | $14.2M | $25.2M | $30.4M | $44.4M | $67.5M | $87.1M | $110.6M | $112.4M | $111.5M | $160.5M | $153.7M | $146.9M | $189.2M | $186.7M | $171.2M | |||
| Retained Earnings Accumulated Deficit | -$454.1M | -$447.0M | -$438.4M | -$411.5M | -$396.3M | -$375.1M | -$346.4M | -$330.1M | -$312.1M | -$275.1M | -$253.3M | -$230.7M | -$179.8M | -$156.4M | -$132.9M | |||
| Restricted Cash Noncurrent | $981.0K | $981.0K | $981.0K | $981.0K | $1.8M | $1.8M | $1.8M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | |||
| Restricted Cash And Cash Equivalents At Carrying Value | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.8M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $1.6M | $584.0K | $584.0K |
| Property Plant And Equipment Net | $1.5M | $1.7M | $2.1M | $3.6M | $4.1M | $4.5M | $5.3M | $5.6M | $6.0M | $6.9M | $6.5M | $6.6M | $5.6M | $4.6M | $3.9M | |||
| Prepaid Expense And Other Assets Current | $2.9M | $2.8M | $2.9M | $2.6M | $2.9M | $3.7M | $5.7M | $4.8M | $5.2M | $3.7M | $4.9M | $5.2M | $9.6M | $3.2M | $4.5M | |||
| Other Liabilities Noncurrent | $133.0K | $133.0K | $132.0K | $0.00 | $0.00 | $0.00 | $43.0K | $43.0K | $43.0K | $200.0K | $200.0K | $204.0K | $217.0K | $233.0K | $321.0K | |||
| Other Assets Noncurrent | $179.0K | $222.0K | $51.0K | $287.0K | $308.0K | $1.8M | $1.3M | $1.0M | $1.0M | $1.0M | $997.0K | $916.0K | $990.0K | $867.0K | $208.0K | |||
| Operating Lease Right Of Use Asset | $19.9M | $20.5M | $21.1M | $16.8M | $17.6M | $18.3M | $19.9M | $20.6M | $21.4M | $22.8M | $22.6M | $23.3M | $25.2M | $26.0M | $11.5M | |||
| Operating Lease Liability Noncurrent | $20.9M | $21.6M | $22.3M | $15.4M | $15.9M | $16.7M | $18.2M | $18.9M | $19.6M | $20.9M | $20.7M | $21.3M | $22.5M | $23.2M | $9.1M | |||
| Operating Lease Liability Current | $2.7M | $2.6M | $2.4M | $2.8M | $3.0M | $2.9M | $2.7M | $2.6M | $2.5M | $2.4M | $2.1M | $2.1M | $2.4M | $2.3M | $1.6M | |||
| Liabilities Current | $10.0M | $12.3M | $13.6M | $18.1M | $17.9M | $16.7M | $18.8M | $17.6M | $16.3M | $24.2M | $18.6M | $19.3M | $23.7M | $19.3M | $12.0M | |||
| Liabilities And Stockholders Equity | $65.1M | $75.5M | $85.9M | $109.3M | $124.2M | $142.9M | $175.4M | $190.7M | $206.2M | $245.5M | $260.2M | $282.8M | $333.6M | $347.1M | $324.6M | |||
| Liabilities | $33.0M | $36.7M | $39.1M | $37.3M | $38.3M | $38.7M | $47.1M | $48.6M | $48.5M | $57.1M | $52.3M | $54.4M | $58.6M | $51.2M | $21.4M | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $1.2M | -$6.5M | $5.6M | $16.6M | $89.9M | -$23.2M | ||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $19.5M | $11.4M | $10.2M | $11.1M | $8.0M | $6.0M | $10.9M | $15.0M | $16.4M | $12.2M | $24.2M | $45.6M | $25.2M | $59.9M | $97.0M | $19.4M | $45.9M | $12.2M |
| Assets Current | $35.6M | $38.3M | $42.5M | $57.1M | $76.6M | $95.1M | $125.5M | $130.7M | $131.6M | $174.8M | $181.3M | $196.1M | $222.5M | $248.2M | $271.2M | |||
| Assets | $65.1M | $75.5M | $85.9M | $109.3M | $124.2M | $142.9M | $175.4M | $190.7M | $206.2M | $245.5M | $260.2M | $282.8M | $333.6M | $347.1M | $324.6M | |||
| Additional Paid In Capital Common Stock | $486.3M | $485.9M | $485.2M | $483.3M | $482.2M | $479.3M | $474.8M | $472.5M | $470.0M | $465.2M | $463.1M | $460.5M | $454.8M | $452.4M | $436.2M | |||
| Accrued Expenses And Other Current Liabilities | $3.8M | $5.4M | $6.5M | $11.8M | $10.3M | $9.7M | $10.5M | $9.9M | $10.3M | $14.8M | $9.6M | $9.4M | $10.9M | $11.0M | $6.0M | |||
| Accounts Payable Current | $1.5M | $1.9M | $1.5M | $1.5M | $2.6M | $2.2M | $3.7M | $3.4M | $1.8M | $3.8M | $3.4M | $4.4M | $5.2M | $1.6M | $2.9M | |||
| Operating Lease Right Of Use Asset Amortization Expense | $615.0K | $773.0K | $719.0K | $1.2M | $530.0K | |||||||||||||
| Accretion Amortization Of Discounts And Premiums Investments | $209.0K | $1.0M | $852.0K | -$466.0K | -$271.0K | |||||||||||||
| Long Term Investments | $6.9M | $13.7M | $19.1M | $30.6M | $23.8M | $21.5M | $21.6M | $31.2M | $44.6M | $38.4M | $47.3M | $54.3M | $77.6M | $65.9M | $36.2M | |||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -$10.0K | -$6.0K | $40.0K | $205.0K | -$44.0K | -$36.0K | -$174.0K | -$229.0K | -$235.0K | -$1.7M | -$1.8M | -$1.4M | -$38.0K | -$23.0K | -$64.0K | |||
| Common Stock Value | $0.00 | $0.00 | $0.00 | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $0.00 | $0.00 | $0.00 | $0.00 | ||||||
| Deferred Offering Costs In Accounts Payable And Accrued Liabilities | $102.0K | $102.0K | $64.0K | $672.0K | ||||||||||||||
| Right Of Use Asset Obtained In Exchange For Operating Lease Liability | $254.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $2.8M | $7.4M | $9.2M | $9.6M | $8.5M | $1.4M |
| Payments To Acquire Marketable Securities | $29.0M | $88.9M | $165.0M | $180.7M | $313.4M | $33.2M |
| Net Cash Provided By Used In Operating Activities | -$39.9M | -$61.3M | -$69.5M | -$76.5M | -$57.1M | -$47.3M |
| Net Cash Provided By Used In Investing Activities | $44.3M | $57.6M | $71.0M | $57.9M | -$232.2M | -$20.6M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$76.0K | -$2.6M | $454.0K | $903.0K | $568.0K | $1.9M |
| Increase Decrease In Other Noncurrent Liabilities | $132.0K | -$43.0K | $1.0K | -$164.0K | $4.0K | $171.0K |
| Increase Decrease In Operating Lease Liabilities | -$2.3M | -$1.4M | -$2.4M | -$2.6M | -$1.2M | -$3.4M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$5.4M | -$4.9M | -$3.4M | $2.8M | $6.7M | $2.9M |
| Depreciation Depletion And Amortization | $1.3M | $1.8M | $1.9M | $1.7M | $1.2M | $611.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $72.4M | $146.3M | $236.2M | $240.5M | $83.5M | $15.9M |
| Increase Decrease In Deferred Revenue | -$4.6M | -$4.7M | -$3.6M | -$2.2M | $15.6M | -$69.0K |
| Net Cash Provided By Used In Financing Activities | $19.0K | $108.0K | $253.0K | $503.0K | $311.1M | $39.6M |
| Payments To Acquire Property Plant And Equipment | $72.0K | $41.0K | $206.0K | $2.0M | $2.3M | $3.3M |
| Proceeds From Issuance Of Common Stock | $19.0K | $108.0K | $253.0K | $503.0K | $1.3M | $294.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $709.0K | $2.3M | $2.5M | $2.9M | $2.1M | $225.0K |
| Payments To Acquire Marketable Securities | $992.0K | $23.1M | $42.9M | $76.1M | $198.1M | $13.2M |
| Net Cash Provided By Used In Operating Activities | -$13.4M | -$16.8M | -$23.4M | -$24.3M | -$16.6M | -$9.6M |
| Net Cash Provided By Used In Investing Activities | $14.6M | $10.2M | $29.0M | $40.8M | -$190.5M | -$13.6M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $169.0K | $130.0K | $1.4M | $2.1M | $1.4M | -$33.0K |
| Increase Decrease In Other Noncurrent Liabilities | $132.0K | -$43.0K | $1.0K | -$4.0K | $2.0K | $8.0K |
| Increase Decrease In Operating Lease Liabilities | -$500.0K | -$652.0K | -$559.0K | -$982.0K | $66.0K | -$1.2M |
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$2.5M | -$3.5M | -$6.6M | -$2.4M | -$88.0K | -$540.0K |
| Depreciation Depletion And Amortization | $399.0K | $458.0K | $467.0K | $357.0K | $272.0K | $101.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $14.6M | $33.3M | $71.9M | $117.5M | $7.6M | |
| Increase Decrease In Deferred Revenue | -$503.0K | -$4.1M | -$683.0K | -$51.0K | -$2.0K | |
| Net Cash Provided By Used In Financing Activities | $0.00 | $0.00 | $107.0K | $297.0M | $34.0K | |
| Payments To Acquire Property Plant And Equipment | $0.00 | $3.0K | $605.0K | $58.0K | $373.0K | |
| Proceeds From Issuance Of Common Stock | $107.0K | $129.0K | $34.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$17.85 | -$33.06 | -$1.83 | -$2.36 | -$2.97 | -$28.89 |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 198.0M |
| Weighted Average Number Of Shares Outstanding Basic | 1.9M | 1.9M | 37.8M | 37.4M | 33.2M | |
| Weighted Average Number Of Diluted Shares Outstanding | 1.9M | 1.9M | 37.8M | 37.4M | 33.2M | |
| Earnings Per Share Basic | $-17.85 | $-33.06 | $-1.83 | $-2.36 | $-2.97 | |
| Common Stock Shares Outstanding | 1.9M | 1.9M | 38.1M | 37.8M | 37.4M | 2.1M |
| Common Stock Shares Issued | 1.9M | 1.9M | 38.1M | 37.8M | 37.4M | 2.1M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 0.00 | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | |||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 33.2M | 2.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$3.72 | -$4.46 | -$0.29 | -$7.93 | -$11.12 | -$0.28 | -$0.43 | -$0.48 | -$0.45 | -$0.58 | -$0.61 | -$0.64 | -$0.63 | -$0.64 | -$1.14 | -$4.73 | -$5.29 | -$4.16 | |
| Common Stock Shares Authorized | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | 200.0M | ||||
| Weighted Average Number Of Shares Outstanding Basic | 1.9M | 1.9M | 38.3M | 1.9M | 1.9M | 38.1M | 37.9M | 37.8M | 37.7M | 37.5M | 37.3M | 37.1M | 37.2M | ||||||
| Weighted Average Number Of Diluted Shares Outstanding | 1.9M | 1.9M | 38.3M | 1.9M | 1.9M | 38.1M | 37.9M | 37.8M | 37.7M | 37.5M | 37.3M | 37.1M | 37.2M | ||||||
| Earnings Per Share Basic | $-3.72 | $-4.46 | $-0.29 | $-7.93 | $-11.12 | $-0.28 | $-0.43 | $-0.48 | $-0.45 | $-0.58 | $-0.61 | $-0.64 | $-0.63 | ||||||
| Common Stock Shares Outstanding | 1.9M | 1.9M | 38.3M | 38.3M | 38.3M | 38.1M | 38.0M | 38.0M | 37.8M | 37.7M | 37.6M | 37.5M | 37.2M | 37.2M | 36.3M | ||||
| Common Stock Shares Issued | 1.9M | 1.9M | 38.3M | 38.3M | 38.3M | 38.1M | 38.0M | 38.0M | 37.8M | 37.7M | 37.6M | 37.5M | 37.2M | 37.2M | 36.3M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | |||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 37.3M | 37.1M | 37.2M | 36.6M | 21.5M | 2.1M | 2.1M | 2.1M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Investment Income Net | $2.5M | $5.3M | $7.0M | $2.2M | $281.0K | $199.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $2.8M | $7.4M | $9.2M | $9.6M | $8.5M | $1.4M |
| Stock Issued During Period Value Stock Options Exercised | $6.0K | $135.0K | $612.0K | $158.0K | ||
| Stock Issued During Period Value Employee Stock Purchase Plan | $19.0K | $108.0K | $247.0K | $368.0K | $640.0K | |
| Capital Expenditures Incurred But Not Yet Paid | $0.00 | $152.0K | $8.0K | $1.0M | $28.0K | |
| Vesting Of Early Exercised Options | $4.0K | $123.0K | ||||
| Other Income | $241.0K | $4.7M | $0.00 | |||
| Vesting Of Exercised Options |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Net | $477.0K | $599.0K | $1.1M | $1.3M | $1.4M | $1.6M | $1.9M | $1.8M | $1.4M | $587.0K | $395.0K | $198.0K | $131.0K | $176.0K | $56.0K | $24.0K | $51.0K | $112.0K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $407.0K | $625.0K | $709.0K | $1.1M | $2.8M | $2.3M | $2.3M | $2.4M | $2.5M | $2.1M | $2.4M | $2.9M | $2.2M | $2.0M | $2.1M | $403.0K | $223.0K | $225.0K |
| Stock Issued During Period Value Stock Options Exercised | $6.0K | $28.0K | $107.0K | $185.0K | $23.0K | $129.0K | $41.0K | $5.0K | $34.0K | |||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $14.0K | $79.0K | $141.0K | $224.0K | $420.0K | |||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $46.0K | $231.0K | $37.0K | $17.0K | ||||||||||||||
| Vesting Of Early Exercised Options | $2.0K | $2.0K | $16.0K | $88.0K | ||||||||||||||
| Other Income | $82.0K | $50.0K | $22.0K | $0.00 | $0.00 | $4.7M | ||||||||||||
| Vesting Of Exercised Options | $2.0K | $10.0K | $5.0K |
Most recent annual filing with the SEC: March 12, 2026
Data sourced from SEC EDGAR public filings as of August 6, 2026.